Posted in | News

Entech Solar Declares Progress in its New Daylighting Products

Entech Solar, which has been developing a number of daylighting products for use in industrial, commercial and educational buildings that utilizes sunlight for power, recently declared the progress it has made in the development of its high-lumen-output collimating skylight and collimating accessory kit for skylights. The company shared the key test results of its first phase of development.

Both the new products incorporate Entech Solar’s registered collimating skylight technology, which is designed to redirect the solar rays to the working area below the skylight thus supplying more and quality sun light to the working spot than the traditional type of skylights. Entech Solar’s High-Lumen-Output Collimating Skylights over the past few weeks during the spring equinox constantly produced over 50,000 lumens of maximum output on normal clear days during the noon period utilizing an above-roof window opening measuring 6.2 square feet. The collimating skylight products are produced utilizing cost- effective manufacturing techniques and materials. The new products are anticipated to be available commercially in the second quarter of this year with competitive prices per lumen of daylight supplied. The company is also planning to offer bigger sized units for the use of warehouses, retail stores and factories. The larger units with an aperture of 13 square feet are anticipated to provide over 100,000 lumens of lighting.

The Collimating Add-On Kits supplied by the company for use with Skylights manufactured by other companies during the tests improved the daylighting features of other skylight products. The add-on products got rid of the glare normally associated with conventional skylight products and efficiently directed the lumen output to the work spot beneath the skylight where required. While around 60% improvements were measured in the mid-mornings the add-ons achieved near 100% improvement in the mid-afternoon period and it was a staggering 130% improvement in the late afternoons and early mornings.

Source: http://www.entechsolar.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Entech Solar Declares Progress in its New Daylighting Products. AZoBuild. Retrieved on November 23, 2024 from https://www.azobuild.com/news.aspx?newsID=13769.

  • MLA

    Scanlon, Joel. "Entech Solar Declares Progress in its New Daylighting Products". AZoBuild. 23 November 2024. <https://www.azobuild.com/news.aspx?newsID=13769>.

  • Chicago

    Scanlon, Joel. "Entech Solar Declares Progress in its New Daylighting Products". AZoBuild. https://www.azobuild.com/news.aspx?newsID=13769. (accessed November 23, 2024).

  • Harvard

    Scanlon, Joel. 2019. Entech Solar Declares Progress in its New Daylighting Products. AZoBuild, viewed 23 November 2024, https://www.azobuild.com/news.aspx?newsID=13769.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.